Secure Trust Bank PLC’s 1H26 investor update highlighted strong progress on its growth strategy, with higher lending, improved profitability, disciplined risk management and increased shareholder returns. Customer lending reached £3.5bn, while adjusted profit before tax rose 9.4% to £31.3m, supported by stable risk-adjusted margins and an improving cost of risk. The CET1 capital ratio increased to 14.3%, comfortably above the bank’s 13% ambition, providing flexibility to fund growth and return capital through an increased interim dividend and £10m share buyback programme. Secure Trust Bank has completed its strategic exit from vehicle finance, simplifying the group around Retail Finance, Business Finance and Savings, while pursuing product expansion, digital capability and capital discipline. New partnerships with Magnet and Centrica British Gas support expansion in home improvement finance, alongside growth in bridging and specialty finance and broader savings distribution. Management is targeting around 10% annual lending growth, a medium-term cost-to-income ratio of 35–40% and return on average equity above 16%, driven by operating leverage, cost efficiencies and disciplined underwriting. With approximately £15m of annualised run-rate cost savings already delivered or committed and further growth opportunities across specialist lending markets, Secure Trust Bank remains focused on improving margins, returns and operational efficiency while maintaining a strong capital position.

Celebrus Technologies PLC’s post-AGM investor update highlighted positive commercial momentum, an improving sales pipeline and a growth strategy targeting sustainable annual recurring revenue (ARR) growth of approximately 20%. Management reported encouraging progress from its strengthened direct sales operation across EMEA and the US, supported by increased marketing activity, stronger lead generation, tighter deal qualification and several opportunities progressing through legal stages. Celebrus also positioned its real-time customer data platform as a potential beneficiary of AI and agentic AI adoption, leveraging proprietary capabilities in compliant identity resolution, accurate digital data capture and millisecond-level data availability to support increasingly sophisticated customer applications. From a financial results perspective, management illustrated that 20% ARR growth would increase Celebrus ARR from £15 million to £18 million, with gross margins of approximately 90% or higher providing significant incremental contribution while supporting continued investment in sales, marketing and customer delivery. The company sees scope for economies of scale to drive stronger profitability over the medium term, with a potential longer-term net margin of around 20%. Investors were also reminded that the transition to straight-line revenue recognition will dampen reported revenue across FY2026-FY2028, meaning cash flow and operating cash flow may provide a clearer indication of underlying company performance during the transition. Standard customer contracts remain three-year agreements, with clients continuing to pay annually in advance.

Nichols PLC’s investor update highlighted the transformational €75 million acquisition of VITHIT, a fast-growing functional soft drinks brand that strengthens the Group’s position in the expanding health and wellness market. VITHIT generated FY2025 sales of approximately €26.5 million, representing a three-year CAGR of nearly 10%, alongside adjusted operating profit of €4.2 million and an operating margin of almost 16%. The acquisition, funded from Nichols’ existing cash resources, is expected to be immediately earnings enhancing and offers significant growth opportunities through expanded UK distribution, international development, new product innovation and annual cost synergies exceeding €1 million. Management expects VITHIT to complement the existing Vimto, Myprotein and Wonderfuel portfolio while providing exposure to growing consumer demand for low-calorie, functional beverages. Nichols also reported strong underlying company performance, including 17% first-half growth in Africa and continued innovation across its Middle East and UK portfolio. With a strong cash-generative, asset-light operating model, clear revenue and margin opportunities, and a disciplined integration strategy, Nichols believes the VITHIT acquisition can accelerate long-term revenue growth, earnings and shareholder returns, with management now focused on integration and organic growth rather than further M&A over the near term.

Ares Strategic Mining Inc. provided an investor update highlighting its transition from exploration and development into commercial fluorspar production at the fully permitted Lost Sheep Mine in Utah. The company is commissioning its metallurgical-grade fluorspar (metspar) lumps plant, with production expected to begin imminently and initial product shipments targeted for the following month. Management said the operation has approximately 12,000 tonnes of high-grade fluorspar already stockpiled and expects the business to become increasingly self-sustaining as revenue generation begins. Ares is targeting annual revenue of approximately US$20–30 million from metspar production before its higher-value acid-grade fluorspar flotation plant comes online, with management expecting this revenue level to be achievable well within three years. The growth strategy includes expanding mine throughput through additional ramps and developing secondary and tertiary targets across its district-scale Utah property. Strong domestic and international demand supports the company's outlook, including its metspar relationship with the Kramer Group and a five-year U.S. Department of Defense contract for acid-grade fluorspar, with the flotation plant targeted for operation in the first half of next year. With revenue approaching, significant processing infrastructure in place and a potential NASDAQ uplisting progressing, Ares Strategic Mining is focused on production ramp-up, operational execution and establishing a strategic domestic supply of critical-mineral fluorspar for U.S. industry.

Plus500 Ltd delivered record financial and operational performance in the first half of 2026, supported by strong momentum across its OTC and rapidly scaling non-OTC businesses. Customer income increased 24% year on year to a five-year high of approximately $461 million, while revenue rose 12%, driven by higher-value customers, geographic expansion and continued investment in customer acquisition, technology and product development. Non-OTC revenue grew approximately 30% and now represents around 15% of Group revenue, with the business on track to deliver annualised revenue of approximately $140 million. Plus500 continued to expand its US futures and CFTC-regulated prediction markets operations across B2B, B2C and B2B2C channels, alongside new strategic partnerships and international expansion. The Group onboarded more than 65,000 new customers, up 17%, while active customers increased 10% to over 197,000 and customer deposits reached $3.4 billion. Plus500 maintained a highly cash-generative, debt-free balance sheet, with operating cash conversion of 99% and approximately $850–860 million of cash at period end. Reflecting its strong financial position, the company announced $182.5 million of additional shareholder returns through dividends and share buybacks, taking total returns announced in 2026 to $370 million. Looking ahead, Plus500's growth strategy remains focused on geographic expansion, customer retention, US futures, prediction markets and proprietary technology, with management confident of delivering full-year financial results in line with current market expectations and generating sustainable long-term growth and shareholder value.

MicroSalt PLC delivered an investor update highlighting accelerating commercialisation of its patented low-sodium salt technology, supported by growing regulatory pressure on global food manufacturers to reduce sodium. The company reported FY2025 revenue of $2.1 million and projects revenue of approximately $4.5 million in 2026, rising to around $15 million in 2027 as a major North American customer rollout scales. Management expects improving margins as production runs increase from approximately 50,000 lbs to 200,000 lbs, generating procurement and manufacturing efficiencies, with MicroSalt targeting cash flow positivity and profitability as volumes ramp during FY2027. The growth strategy remains focused on major global food manufacturers, including a four-year joint development agreement with a key customer and opportunities across multiple brands, product categories and international markets. MicroSalt is also expanding its product portfolio through MicroSalt Premium and MicroSalt Fibre, while pursuing applications spanning snacks, bread, soups, sauces and other food categories. With a capital-light contract manufacturing model, approximately five million kilograms of current production capacity and a 60-month product shelf life, the company believes it is positioned to support larger-scale customer demand. Management emphasised its long-term revenue growth opportunity, patented technology, strengthening customer relationships and increasing scale efficiencies, while noting that lengthy testing and procurement cycles can make revenue growth uneven between major commercial rollouts.

Primary Health Properties PLC (PHP) reported a strong set of interim results for the six months ended 30 June 2026, highlighting the benefits of its transformational merger with Assura and continued momentum across its UK and Irish healthcare property portfolio. Adjusted earnings increased to £98 million, while adjusted earnings per share rose 9% to 3.8p, supported by additional income from Assura, rental growth and merger synergies. PHP has delivered £8 million, or 92%, of its anticipated £9 million cost synergies, reducing its EPRA cost ratio to 8.7%. Like-for-like rental growth generated an additional £4 million of income, with annualised rental growth reaching 3.2% and open-market rent reviews delivering a 6.3% uplift. The £6 billion healthcare property portfolio maintained 99% occupancy, while the average cost of debt remained at 3.8% and is expected to fall to 3.5% following further deleveraging. PHP is progressing joint ventures across primary care and private hospitals, with proceeds expected to repay the remaining £260 million bridge facility and reduce loan-to-value towards the low-50% range. Management also highlighted a growing development and asset management pipeline, supported by government-backed healthcare demand, neighbourhood health centre investment and attractive demographic trends. With integration substantially complete, 30 consecutive years of dividend growth and increasing scale following the Assura merger, PHP remains focused on earnings growth, rental growth, disciplined capital management and long-term shareholder returns.

Atalaya Mining’s Q2 and H1 2026 investor update highlights strong company performance, with copper production reaching 23,400 tonnes in the first half and EBITDA rising to a record €126 million. Revenue reached €264 million, supported by higher copper and silver prices, while cash costs remained resilient at approximately $2.43 per pound despite inflation in diesel, explosives and other operating inputs. The company generated €58 million of free cash flow in Q2 and ended the period with almost €320 million of net cash, enabling a 25% increase in the interim dividend. Atalaya maintained its copper production guidance, targeting the lower end of the range, while expecting cash costs to remain within guidance. Its growth strategy focuses on Rio Tinto expansion, San Dionisio, Masa Valverde and the major Touro project, alongside further processing opportunities at its plant. Management expects these projects to support a potential path toward approximately 100,000 tonnes of copper equivalent production, reinforcing Atalaya Mining’s long term growth outlook and financial strength.

Persimmon PLC reported a strong 2026 half-year performance despite challenging UK housing market conditions, with underlying profit before tax rising 3% to £170 million and completions increasing 13% to 5,189 homes, supported by higher sales rates and growth across its Persimmon, Charles Church and Westbury brands. First-time buyer completions rose 14%, while the company retained its five-star customer rating and strengthened its land and planning pipeline, securing detailed permission on more than 6,100 plots. Persimmon’s forward order book stands at £1.9 billion, up 3%, including a £1.3 billion private order book, up 5%, providing strong visibility for future revenue and growth. While operating margins reduced from 13.1% to 12.8%, volume leverage and tight overhead control helped mitigate cost pressures. The company expects around £40–50 million of additional build cost inflation over the next 18 months but is pursuing efficiency measures, vertical integration and AI investment to protect margins. With approximately 81,000 owned and controlled plots, a further 82,000 strategic land plots and £1 billion of committed bank facilities, Persimmon remains focused on disciplined investment and shareholder returns. Management now expects approximately 12,500 home completions in 2026, at the upper end of previous guidance, while maintaining its medium-term ambitions of a 20% operating margin and 20% return on capital.

Xaar PLC’s H1 2026 investor update highlighted resilient company performance despite global economic uncertainty, with group revenue increasing 9.2% year-on-year and core printhead revenue rising 5.5%. Growth was driven by new applications and expanding demand for Xaar’s high-viscosity, high-pigment printhead technology, while adjusted profit before tax improved to £0.2 million from a £0.7 million loss in H1 2025. Gross margin increased by 220 basis points, supported by operational gearing and continued cost control, while Megnajet delivered 27% revenue growth and a 120 basis-point improvement in gross margin. Xaar continues to diversify beyond its historic ceramics market, now generating revenue across 21 sectors including advanced manufacturing, semiconductor, solar, automotive and 3D printing. The delayed FlashForge desktop 3D printing launch remains a key growth catalyst, with initial production orders received and Xaar supporting the customer’s manufacturing ramp-up ahead of an expected launch in the coming months. The Company is also progressing opportunities in semiconductor manufacturing, conformal PCB coating, solar panels and advanced ceramic applications, where its ability to print challenging high-viscosity fluids provides a differentiated competitive advantage. Xaar is investing in R&D, engineering and new manufacturing capacity while strengthening its balance sheet liquidity through expanded credit facilities. With a growing application pipeline, increasing installed base and recurring replacement printhead revenue, management remains confident in the Group’s long-term growth strategy and future prospects.